US Stock MarketDetailed Quotes

Ocular Therapeutix (OCUL)

Watchlist
  • 8.625
  • +0.120+1.41%
Trading Jul 27 15:02 ET
1.89BMarket Cap-5.99P/E (TTM)

Ocular Therapeutix (OCUL) Revenue Breakdown Overview

By Business/Source

Currency:USD
2026/Q1
Stock NameRevenueRatio
Developing and commercializing innovative therapies for retinal diseases and other eye conditions10.79M100.00%

By Country/Region

Currency:USD
2025/FY
Stock NameRevenueRatio
United States51.82M99.75%
China128K0.25%
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
Signs of de-escalation in U.S.-Iran military tensions have emerged, pushing international oil prices lower. Trump ordered the U.S. military Show More